posts browsing tag

NGS

– Macrogen is the first and only NGS-based institute in Korea to receive GCLP accreditation – Increased demands from multinational pharmaceutical companies for NGS analysis for companion diagnostics and targeted anti-cancer drugs – Expected growth in revenue by entering into the clinical trial market with a new profit …

Continue reading

SEOUL, South Korea–The precision medicine and biotechnology company, Macrogen (CEO Kap-Seok Yang, www.macrogen.com) (KOSDAQ: 038290), announced on December 20 that its NGS clinical laboratories in Seoul headquarters and Bundang Precision Medicine Center had officially received CLIA (Clinical Laboratory Improvement Amendments) accreditation, as the first in …

Continue reading

Macrogen looks forward to seeing you at the Saudi International Medlab Expo until Nov 21st! Don’t miss a great opportunity to have a meeting with Macrogen! Our booth is #A53! Experts from Sanger sequencing, NGS and Clinical Diagnostics are waiting for you🙂 Macrogen can visit wherever you want …

Continue reading

ROCKVILLE, MD– Macrogen Corp. (www.macrogenlab.com) announces that its Clinical Lab that provides clinical NGS services has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP) based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs …

Continue reading
Continue reading